SCHEMBL6388043

SCHEMBL6388043

O=C(CCCCS(=O)(=O)c1ccc(-c2ccc(Cl)cc2)cc1)NO

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 11/20 0.65
HDAC1 Q13547 10/20 0.65
HDAC3 O15379 8/20 0.65
HDAC4 P56524 8/20 0.65
HDAC7 Q8WUI4 8/20 0.65
HDAC10 Q969S8 8/20 0.65
HDAC11 Q96DB2 8/20 0.65
HDAC8 Q9BY41 8/20 0.65
HDAC6 Q9UBN7 8/20 0.65
HDAC9 Q9UKV0 8/20 0.65
HDAC5 Q9UQL6 8/20 0.65
MMP1 P03956 5/20 0.63
MEP1B Q16820 1/20 0.56
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
MMP3 P08254 2/20 0.49
MMP2 P08253 1/20 0.49
MMP7 P09237 1/20 0.49
MMP9 P14780 1/20 0.49
MMP13 P45452 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6387224 0.99 HDAC1 (0.68) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL6386202 0.80 MEP1B (0.67) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL7324083 0.79 HDAC1 (1.00) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL6384827 0.79 MEP1B (0.70) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL6386199 0.78 HDAC1 (0.88) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL10583534 0.77 HDAC1 (0.53) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL7996970 0.77 HDAC1 (0.65) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL10580753 0.77 HDAC1 (0.53) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL7010857 0.75 HSD11B1 (0.58) MMP1KMT2AMEN1MMP2MMP7
SCHEMBL8290529 0.75 ALDH1A1 (0.72) MMP1MEP1BKMT2AMEN1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119305-A1 Il-6 production inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US claimed
US-20050119305-A1 Il-6 production inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119305-A1 Il-6 production inhibitors IL6, IL6ST, PADI6 HDAC2 2783/4885HDAC1 1343/4885HDAC3 1988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.